AMC ENTERTAINMENT HOLDINGS, INC. vs Citius Pharmaceuticals Inc — how do they compare? AMC ENTERTAINMENT HOLDINGS, INC. trades at $2.41 (market cap $2.14B), while Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M). The key difference: AMC ENTERTAINMENT HOLDINGS, INC. is far larger — about 106.9× Citius Pharmaceuticals Inc's market cap, and AMC ENTERTAINMENT HOLDINGS, INC. pays a 0.11% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMC | CTXR | |
|---|---|---|
Market Cap | $2.14B | $20.01M |
Sector | Media | Health |
52-Week High | $3.15 | $1.82 |
52-Week Low | $0.95 | $0.48 |
Enterprise Value | $9.08B | $16.23M |
Dividend Yield | 0.11% | — |
Signals from Pluang's Aura AI — not financial advice
AMC trades at $2.42, down 6.56% today, yet maintains a bullish technical signal with strong recent earnings beats. The company reported record Q2 2026 revenue and EBITDA, driven by surging attendance and premium screen growth. However, negative net income and substantial debt of $4.01 billion highlight financial strain. Analyst consensus is a $3.00 price target with mixed ratings (32% Buy, 46% Hold).
The outlook hinges on sustained box office recovery and cash flow improvement, with management citing a potential cash-flow breakthrough. Key risks include high leverage, dependence on film slate success, and meme-stock volatility. Upside exists if operational momentum continues, but the negative equity position warrants caution.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
AMC Entertainment Holdings, Inc. operates as a holding company. The Company, through its subsidiaries, provides theatrical exhibition, movie screening, food distribution, online ticket booking, and other related services. AMC Entertainment offers movie theaters worldwide.
Read more on AMC →Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →